Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 12 de 12
Filtrar
1.
Pediatr Dev Pathol ; 23(1): 8-22, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-31791203

RESUMEN

Diagnosis or exclusion of Hirschsprung disease (HSCR) is a frequent exercise in any pediatric hospital. Although HSCR may present at different ages and with varied clinical findings, the most common presentation is a neonate with severe constipation or signs of intestinal obstruction. A variety of diagnostic tests including contrast enema and anorectal manometry may be used as diagnostic screens, but diagnosis ultimately rests upon histopathological evaluation of a rectal biopsy. For the experienced pathologist, conventional hematoxylin-and-eosin-stained sections often suffice to exclude HSCR or establish the diagnosis. However, ancillary diagnostic tests such as acetylcholinesterase histochemistry or calretinin immunohistochemistry are complementary and extremely helpful in some cases. In this Perspectives article, we review the clinical and pathological features of HSCR, highlight those that are found in most patients, and discuss how to address particularly challenging aspects of the diagnostic workup.


Asunto(s)
Colon/anomalías , Técnicas de Diagnóstico del Sistema Digestivo , Enfermedad de Hirschsprung/diagnóstico , Recto/anomalías , Adolescente , Biomarcadores/análisis , Biopsia , Niño , Preescolar , Colon/química , Colon/patología , Enfermedad de Hirschsprung/metabolismo , Enfermedad de Hirschsprung/patología , Humanos , Inmunohistoquímica , Lactante , Recién Nacido , Valor Predictivo de las Pruebas , Recto/química , Recto/patología , Coloración y Etiquetado
2.
AIDS Behav ; 17(3): 1002-15, 2013 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-23114512

RESUMEN

We assessed the acceptability of three of over-the-counter products representative of potential rectal microbicide (RM) delivery systems. From 2009 to 2010, 117 HIV-uninfected males (79 %) and females (21 %) who engage in receptive anal intercourse participated in a 6-week randomized crossover acceptability trial. Participants received each of three products (enema, lubricant-filled applicator, suppository) every 2 weeks in a randomized sequence. CASI and T-ACASI scales assessed product acceptability via Likert responses. Factor analysis was used to identify underlying factors measured by each scale. Random effects models were fit to examine age and gender effects on product acceptability. Three underlying factors were identified: Satisfaction with Product Use, Sexual Pleasure, and Ease of Product Use. For acceptability, the applicator ranked highest; however, differences between product acceptability scores were greatest among females and younger participants. These findings indicate that RM delivery systems impact their acceptability and should be considered early in RM development to enhance potential use.


Asunto(s)
Antiinfecciosos Locales/administración & dosificación , Antiinfecciosos Locales/efectos adversos , Sistemas de Liberación de Medicamentos/métodos , Infecciones por VIH/prevención & control , Aceptación de la Atención de Salud/psicología , Recto/efectos de los fármacos , Administración Rectal , Adulto , Estudios Cruzados , Sistemas de Liberación de Medicamentos/instrumentación , Enema/estadística & datos numéricos , Femenino , Humanos , Lubricantes/administración & dosificación , Lubricantes/efectos adversos , Masculino , Persona de Mediana Edad , Recto/química , Conducta Sexual , Supositorios/administración & dosificación , Supositorios/efectos adversos , Resultado del Tratamiento
3.
Int J Radiat Oncol Biol Phys ; 85(5): 1232-8, 2013 Apr 01.
Artículo en Inglés | MEDLINE | ID: mdl-23158058

RESUMEN

PURPOSE: Preoperative chemoradiation therapy (CRT) significantly decreases local recurrence in locally advanced rectal cancer. Various biomarkers in biopsy specimens obtained before CRT have been proposed as predictors of response. However, reliable biomarkers remain to be established. METHODS AND MATERIALS: The study group comprised 101 consecutive patients with locally advanced rectal cancer who received preoperative CRT with oral uracil/tegafur (UFT) or S-1. We evaluated histologic findings on hematoxylin and eosin (H&E) staining and immunohistochemical expressions of Ki67, p53, p21, and apoptosis in biopsy specimens obtained before CRT and 7 days after starting CRT. These findings were contrasted with the histologic response and the degree of tumor shrinkage. RESULTS: In biopsy specimens obtained before CRT, histologic marked regression according to the Japanese Classification of Colorectal Carcinoma (JCCC) criteria and the degree of tumor shrinkage on barium enema examination (BE) were significantly greater in patients with p21-positive tumors than in those with p21-negative tumors (P=.04 and P<.01, respectively). In biopsy specimens obtained 7 days after starting CRT, pathologic complete response, histologic marked regression according to both the tumor regression criteria and JCCC criteria, and T downstaging were significantly greater in patients with apoptosis-positive and p21-positive tumors than in those with apoptosis-negative (P<.01, P=.02, P=.01, and P<.01, respectively) or p21-negative tumors (P=.03, P<.01, P<.01, and P=.02, respectively). The degree of tumor shrinkage on both BE as well as MRI was significantly greater in patients with apoptosis-positive and with p21-positive tumors than in those with apoptosis-negative or p21-negative tumors, respectively. Histologic changes in H&E-stained biopsy specimens 7 days after starting CRT significantly correlated with pathologic complete response and marked regression on both JCCC and tumor regression criteria, as well as with tumor shrinkage on BE and MRI (P<.01, P<.01, P<.01, P<.01, and P=.03, respectively). CONCLUSIONS: Immunohistochemical expressions of p21 and apoptosis together with histologic changes on H&E-stained biopsy specimens obtained 7 days after starting CRT are strong predictors of the response to CRT.


Asunto(s)
Adenocarcinoma/patología , Adenocarcinoma/terapia , Quimioradioterapia , Neoplasias del Recto/patología , Neoplasias del Recto/terapia , Recto/patología , Adenocarcinoma/química , Adulto , Anciano , Anciano de 80 o más Años , Antimetabolitos Antineoplásicos/uso terapéutico , Apoptosis , Biomarcadores de Tumor/análisis , Biopsia , Inhibidor p21 de las Quinasas Dependientes de la Ciclina/análisis , Combinación de Medicamentos , Femenino , Humanos , Antígeno Ki-67/análisis , Masculino , Persona de Mediana Edad , Ácido Oxónico/uso terapéutico , Neoplasias del Recto/química , Recto/química , Tegafur/uso terapéutico , Factores de Tiempo , Resultado del Tratamiento , Carga Tumoral/efectos de los fármacos , Carga Tumoral/efectos de la radiación , Proteína p53 Supresora de Tumor/análisis
4.
Zhen Ci Yan Jiu ; 37(4): 277-80, 2012 Aug.
Artículo en Chino | MEDLINE | ID: mdl-23140047

RESUMEN

OBJECTIVE: To observe the effect of traditional manipulations of "Shaoshanhuo" (heat-producing needling) and "Toutianliang"(cool-producing needling) on body temperature and serum endotoxin level in heat syndrome rabbits. METHODS: Twenty-four Japanese rabbits were randomly divided into control, model, Shaoshanhuo and Toutianliang groups. Heat-syndrome model was established by subcutaneous injection of bacterium coli endotoxin solution (40 microg/mL, 2 mL/kg). Heat-producing and cool-producing needling was applied to bilateral "Quchi" (LI 11) for 5 min, respectively. Rectal temperature was detected by using a thermometer, and serum endotoxin content assayed by using Limulus Ameboyte Lysate kit (luminescence measuring). RESULTS: In comparison with the control group, both rectal temperature and serum endotoxin levels were increased significantly in the model group (P < 0.01). While compared to the model group, the rectal temperature and serum endotoxin levels were down-regulated considerably in both Shaoshanhuo and Toutianliang groups (P < 0.05, P < 0.01). The effect of the Toutianliang group was obviously superior to that of the Shaoshanhuo group in reducing serum endotoxin content (P < 0.01). CONCLUSION: Both heat-producing needling and cool-producing needling can lower rectal temperature and serum endotoxin levels in heat-syndrome rabbits, and the effect of cool-producing needling is relatively better in reducing endotoxin content.


Asunto(s)
Terapia por Acupuntura/métodos , Endotoxinas/efectos adversos , Trastornos de Estrés por Calor/terapia , Recto/química , Terapia por Acupuntura/instrumentación , Animales , Temperatura Corporal , Endotoxinas/sangre , Femenino , Trastornos de Estrés por Calor/etiología , Trastornos de Estrés por Calor/fisiopatología , Humanos , Masculino , Agujas , Conejos
5.
Int J Radiat Oncol Biol Phys ; 83(4): 1113-9, 2012 Jul 15.
Artículo en Inglés | MEDLINE | ID: mdl-22172905

RESUMEN

PURPOSE: MicroRNAs (miRNAs) are small, noncoding RNA molecules that can be down- or upregulated in colorectal cancer and have been associated to prognosis and response to treatment. We studied miRNA expression in tumor biopsies of patients with rectal cancer to identify a specific "signature" correlating with pathological complete response (pCR) after neoadjuvant chemoradiotherapy. METHODS AND MATERIALS: A total of 38 T3-4/N+ rectal cancer patients received capecitabine-oxaliplatin and radiotherapy followed by surgery. Pathologic response was scored according to the Mandard TRG scale. MiRNA expression was analyzed by microarray and confirmed by real-time Reverse Transcription Polymerase Chain Reaction (qRT-PCR) on frozen biopsies obtained before treatment. The correlation between miRNA expression and TRG, coded as TRG1 (pCR) vs. TRG >1 (no pCR), was assessed by methods specifically designed for this study. RESULTS: Microarray analysis selected 14 miRNAs as being differentially expressed in TRG1 patients, and 13 were confirmed by qRT-PCR: 11 miRNAs (miR-1183, miR-483-5p, miR-622, miR-125a-3p, miR-1224-5p, miR-188-5p, miR-1471, miR-671-5p, miR-1909∗, miR-630, miR-765) were significantly upregulated in TRG1 patients, 2 (miR-1274b, miR-720) were downexpressed. MiR-622 and miR-630 had a 100% sensitivity and specificity in selecting TRG1 cases. CONCLUSIONS: A set of 13 miRNAs is strongly associated with pCR and may represent a specific predictor of response to chemoradiotherapy in rectal cancer patients.


Asunto(s)
Quimioradioterapia Adyuvante/métodos , MicroARNs/análisis , Terapia Neoadyuvante/métodos , ARN Neoplásico/análisis , Neoplasias del Recto/genética , Neoplasias del Recto/terapia , Adulto , Anciano , Antineoplásicos/uso terapéutico , Biopsia , Capecitabina , Desoxicitidina/administración & dosificación , Desoxicitidina/análogos & derivados , Femenino , Fluorouracilo/administración & dosificación , Fluorouracilo/análogos & derivados , Humanos , Masculino , Análisis por Micromatrices/métodos , Persona de Mediana Edad , Compuestos Organoplatinos/administración & dosificación , Oxaliplatino , Neoplasias del Recto/patología , Recto/química , Recto/patología , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa/métodos , Sensibilidad y Especificidad
6.
Br J Surg ; 95(4): 477-83, 2008 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-18256993

RESUMEN

BACKGROUND: Sacral nerve stimulation (SNS) may improve faecal incontinence by modulating rectal sensation. This study measured changes in the peripheral expression of various neural epitopes in response to SNS. METHODS: Rectal mucosal biopsies were taken from 12 patients before and after temporary SNS, and from ten responders at 90 days after permanent stimulation. Sections were immunostained for substance P, transient receptor potential vanilloid (TRPV) 1, vasoactive intestinal peptide (VIP) and calcitonin gene-related peptide (CGRP). Levels were compared with those in nine continent controls. RESULTS: Baseline levels of percentage area immunoreactivities of substance P (median 0.51 (95 per cent confidence interval 0.31 to 0.73) versus 0.13 (0.07 to 0.27) per cent; P < 0.001) and TRPV1 (0.76 (0.41 to 1.11) versus 0.09 (0.04 to 0.14) per cent; P < 0.001), but not of VIP (1.26 (0.37 to 2.15) versus 1.28 (0.39 to 2.17); P = 0.943), were significantly greater than in controls. Successful SNS resulted in a significant decrease in substance P immunostaining after temporary (0.15 (0.06 to 0.51) per cent; P = 0.051) and permanent (0.17 (0 to 0.46) per cent; P = 0.051) stimulation. Immunoreactivity of TRPV1, VIP, CGRP and neural markers showed no qualitative change. CONCLUSION: Patients with faecal incontinence demonstrate normalization of raised rectal mucosal substance P levels following successful SNS.


Asunto(s)
Terapia por Estimulación Eléctrica/métodos , Incontinencia Fecal/terapia , Mucosa Intestinal/química , Plexo Lumbosacro , Recto/química , Sustancia P/metabolismo , Adulto , Anciano , Péptido Relacionado con Gen de Calcitonina/metabolismo , Electrodos Implantados , Incontinencia Fecal/metabolismo , Incontinencia Fecal/fisiopatología , Humanos , Inmunohistoquímica , Persona de Mediana Edad , Sensación/fisiología , Canales Catiónicos TRPV/metabolismo
7.
Lipids Health Dis ; 5: 6, 2006 Mar 20.
Artículo en Inglés | MEDLINE | ID: mdl-16549021

RESUMEN

BACKGROUND: A high dietary intake of n-6 compared to n-3 fatty acids (FAs) may promote the production of pro-inflammatory eicosanoids and cytokines. In two recent studies, short-term (10-day) duodenal administration of n-3 polyunsaturated fatty acid rich seal oil ameliorated joint pain in patients with inflammatory bowel disease (IBD). Using unpublished data from these two studies we here investigated whether normalisation of the n-6 to n-3 FA ratio in blood and tissues by seal oil administration was associated with improved health related quality of life (HRQOL) as assessed by the generic short-form 36 (SF-36) questionnaire. RESULTS: In the first pilot study, baseline n-6 to n-3 FA ratio in rectal mucosal biopsies from 10 patients with IBD (9 of those had joint pain) was significantly increased compared with that in 10 control patients without IBD or joint pain. Following seal oil administration, the n-6 to n-3 FA ratio of the IBD-patients was significantly lowered to the level seen in untreated controls. In the subsequent, randomized controlled study (n = 19), seal oil administration reduced the n-6 to n-3 FA ratio in blood similarly and also the SF-36 assessed bodily pain, while n-6 FA rich soy oil administration had no such effect. CONCLUSION: In these two separate studies, short-term duodenal administration of seal oil normalised the n-6 to n-3 FA ratio in rectal mucosa and improved the bodily pain dimension of HRQOL of patients with IBD-related joint pain. The possibility of a causal relationship between n-6 to n-3 FA ratio in rectal mucosa and bodily pain in IBD-patients warrants further investigations.


Asunto(s)
Artralgia/prevención & control , Grasas Insaturadas en la Dieta/farmacología , Ácidos Grasos Omega-3/análisis , Ácidos Grasos Omega-6/análisis , Enfermedades Inflamatorias del Intestino/dietoterapia , Enfermedades Inflamatorias del Intestino/metabolismo , Mucosa Intestinal/química , Recto/química , Anciano , Animales , Artralgia/fisiopatología , Biopsia , Grasas Insaturadas en la Dieta/administración & dosificación , Grasas Insaturadas en la Dieta/análisis , Duodeno , Ácidos Grasos Omega-3/metabolismo , Ácidos Grasos Omega-3/farmacología , Ácidos Grasos Omega-6/metabolismo , Aceites de Pescado/farmacología , Humanos , Enfermedades Inflamatorias del Intestino/fisiopatología , Mucosa Intestinal/metabolismo , Ácido Linoleico/análisis , Ácido Linoleico/farmacología , Masculino , Persona de Mediana Edad , Proyectos Piloto , Calidad de Vida , Phocidae , Aceite de Soja/farmacología , Encuestas y Cuestionarios , Factores de Tiempo
8.
Nutr Cancer ; 41(1-2): 150-5, 2001.
Artículo en Inglés | MEDLINE | ID: mdl-12094618

RESUMEN

Epidemiological evidence suggests that dietary calcium and vitamin D intake are inversely related to incidence of colon cancer. Previous studies have demonstrated that supplementation of the diet with calcium in the form of calcium tablets or low-fat dairy foods alters colonic epithelial cell proliferation from a higher- to a lower-risk pattern. The present study compared relative effects of administration of calcium carbonate at approximately 900 mg/day (calcium) with those of a low-fat dairy food diet providing about the same amount of calcium (dairy) in a cross-over "head-to-head" study of 40 subjects at risk for colonic neoplasia. Dietary intake of macronutrients was similar in the two study periods, except for a slight increase in protein intake during dairy calcium supplementation. Rectal epithelial cell proliferation was studied in flat endoscopically normal-appearing mucosa at baseline and at the end of each of the two study periods and showed a significant reduction in epithelial crypt cell labeling index from 12.5% to 9.1% (calcium) or 9.3% (dairy) as well as in proliferating cells in the upper 40% of the crypt from 0.09 to 0.03 in the calcium- and low-fat dairy-supplemented intervention groups. No significant changes in two epithelial cell differentiation markers, cytokeratin AE1 and acidic mucins, were found. Furthermore, there were no differences in epithelial cell apoptosis or expression of the proapoptotic gene product BAK. These data indicate that increased dietary calcium given as supplements or in the diet in low-fat dairy foods lowers epithelial cell proliferation indexes from a higher- to a lower-risk pattern. Because supplemental calcium has been shown to reduce the recurrence of colonic adenomatous polyps in patients at increased risk for colonic neoplasia, our data suggest that supplemental low-fat dairy foods may also be effective.


Asunto(s)
Calcio de la Dieta/administración & dosificación , Diferenciación Celular/efectos de los fármacos , División Celular/efectos de los fármacos , Colon/patología , Productos Lácteos , Dieta con Restricción de Grasas , Poliposis Adenomatosa del Colon/patología , Apoptosis , Biopsia , Carbonato de Calcio/administración & dosificación , Colon/química , Neoplasias del Colon/patología , Dieta , Suplementos Dietéticos , Células Epiteliales/patología , Femenino , Humanos , Queratinas/análisis , Masculino , Proteínas de la Membrana/genética , Persona de Mediana Edad , Mucinas/análisis , Grupos Raciales , Recto/química , Recto/patología , Proteína Destructora del Antagonista Homólogo bcl-2
9.
Poult Sci ; 79(9): 1311-9, 2000 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-11020077

RESUMEN

A feeding experiment was carried out over 42 d with four groups of broiler chickens fed experimental diets formulated to provide no supplementation, 20 mg zinc bacitracin, 60 mg salinomycin, or both feed additives in combination. During the fifth week of the experiment, four chickens from each pen were killed, and the contents of gizzard, duodenum, jejunum, ileum, ceca, and rectum were separately collected and pooled. In all intestinal segments, the pH and the concentration of lactic acid were measured, and the numbers of anaerobic bacteria, coliforms, lactic acid bacteria, lactobacilli, enterococci, and Clostridium perfringens were counted. In homogenates of pancreas obtained from four animals, the activities of amylase, lipase, trypsin, and chymotrypsin were measured. A significant growth-promoting effect was observed in the group receiving zinc bacitracin in combination with salinomycin. Zinc bacitracin significantly reduced the number of coliform bacteria in the ileum and increased the activities of amylase and lipase in pancreas homogenates. Supplementation with salinomycin and zinc bacitracin, alone or in combination, resulted in significantly lower counts of C. perfringens as well as Lactobacillus salivarius, which was a dominant lactic acid bacterium found in broiler intestinal contents. High numbers of these lactobacilli may play a role in broiler growth depression related to competition in nutrient uptake or impaired fat absorption due to bile acid deconjugation.


Asunto(s)
Antibacterianos/farmacología , Bacitracina/farmacología , Pollos/crecimiento & desarrollo , Pollos/microbiología , Sistema Digestivo/microbiología , Piranos/farmacología , Amilasas/metabolismo , Animales , Ciego/química , Ciego/microbiología , Clostridium perfringens/efectos de los fármacos , Recuento de Colonia Microbiana , Sistema Digestivo/química , Duodeno/química , Duodeno/microbiología , Femenino , Molleja de las Aves/química , Molleja de las Aves/microbiología , Concentración de Iones de Hidrógeno , Íleon/química , Íleon/microbiología , Yeyuno/química , Yeyuno/microbiología , Ácido Láctico/análisis , Lactobacillus/efectos de los fármacos , Lipasa/metabolismo , Masculino , Páncreas/efectos de los fármacos , Páncreas/enzimología , Recto/química , Recto/microbiología
10.
Dig Dis Sci ; 40(2): 396-401, 1995 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-7851205

RESUMEN

Recent investigations have demonstrated a protective role for folic acid in dysplasia and neoplasia, through an unknown mechanism. The current study was designed to evaluate whether the protective role of folic acid is due, in part, to its antiproliferative properties. In addition, because colorectal neoplasia is more common with increasing age, we have compared results in both old (22 months) and young (3 months) rats. Colorectal mucosal explants of rats treated with the known carcinogen methylazoxymethanol, were supplemented with folic acid. Ornithine decarboxylase was then measured as an index of cellular proliferative activity. We observed that supplemental folic acid suppressed carcinogen-induced ornithine decarboxylase activity by 64% in the old and 74% in the young rats. Furthermore, a similar phenomenon was observed for tyrosine kinase, which was measured for comparison. The suppression of hyperproliferative activity by supplemental folic acid may contribute to the protective effect of folic acid in colorectal neoplasia.


Asunto(s)
Envejecimiento/efectos de los fármacos , Colon/efectos de los fármacos , Ácido Fólico/farmacología , Mucosa Intestinal/efectos de los fármacos , Acetato de Metilazoximetanol/farmacología , Recto/efectos de los fármacos , Envejecimiento/metabolismo , Análisis de Varianza , Animales , Colon/química , Colon/enzimología , Mucosa Intestinal/química , Mucosa Intestinal/enzimología , Masculino , Técnicas de Cultivo de Órganos , Ornitina Descarboxilasa/análisis , Ornitina Descarboxilasa/efectos de los fármacos , Proyectos Piloto , Proteínas Tirosina Quinasas/análisis , Proteínas Tirosina Quinasas/efectos de los fármacos , Ratas , Ratas Endogámicas F344 , Recto/química , Recto/enzimología , Organismos Libres de Patógenos Específicos
11.
Nutr Cancer ; 24(1): 23-31, 1995.
Artículo en Inglés | MEDLINE | ID: mdl-7491295

RESUMEN

The quantity of beta-carotene (BC) accumulated in colonic polyps and colonic cancerous tissue in humans in situ was determined relative to the quantity accumulated in normal colon and rectal tissue. Serum concentration of BC, retinol, and alpha-tocopherol and tissue BC concentration were determined by high-performance liquid chromatography in samples obtained before and after oral supplementation with BC (30 mg/day). The serum BC and retinol concentrations significantly increased in response to supplementation in control, polyp, and cancer patients, but there was no change in serum alpha-tocopherol concentration. The BC concentration in tissue (colon, rectum, and tumor) of cancer patients was significantly less than that in tissue samples from control and polyp patients. Relative to baseline values, BC accumulated to a significant extent in tissues from all patients, including polyp and tumor tissue, during supplementation. The results indicate that BC does accumulate in colonic neoplastic tissue in humans and may potentially be utilized to augment cytotoxicity of chemotherapeutics or to prevent malignant transformation of cells.


Asunto(s)
Carotenoides/metabolismo , Colon/metabolismo , Neoplasias del Colon/metabolismo , Pólipos del Colon/metabolismo , Recto/metabolismo , Pólipos Adenomatosos/química , Pólipos Adenomatosos/metabolismo , Anciano , Anciano de 80 o más Años , Carotenoides/análisis , Carotenoides/sangre , Cromatografía Líquida de Alta Presión , Colon/química , Neoplasias del Colon/química , Pólipos del Colon/química , Femenino , Humanos , Mucosa Intestinal/química , Mucosa Intestinal/metabolismo , Masculino , Persona de Mediana Edad , Recto/química , Vitamina A/análisis , Vitamina A/sangre , Vitamina E/análisis , Vitamina E/sangre , beta Caroteno
12.
J Surg Res ; 57(6): 718-25, 1994 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-7527880

RESUMEN

Gut mucosal ischemia has been associated with cardiopulmonary bypass (CPB) and may contribute to postoperative systemic inflammatory response and multiorgan dysfunction. Hypertonic saline/dextran (HSD) has been previously shown to selectively increase mucosal blood flow in circulatory shock. To determine whether adding HSD to the prime solution for CPB improves gut mucosal blood flow and oxygenation, we performed normothermic, non-cross-clamped CPB in pigs with 1 ml/kg of HSD (25% NaCl/24% dextran 70) (HSD group, n = 9) or lactated Ringer's solution (LRS group, n = 9) as control added to a standard prime. Animals were instrumented with ultrasonic flow probes on the superior mesenteric artery (SMA), laser Doppler mucosal flow probes in the ileum, and indwelling portal vein catheters and tonometers for mucosal hydrogen ion measurements and pH calculations in the stomach, ileum, and rectum. The total infused volume and net fluid balance was significantly lower in the HSD than in the LRS group (649 +/- 171 ml vs 2075 +/- 385 ml and 502 +/- 182 ml vs 1891 +/- 363 ml, respectively, P < 0.01). SMA flow in the LRS group increased to 110-123% of baseline during CPB and was significantly higher than that in the HSD group which remained unchanged. Ileal mucosal blood flow decreased significantly to 70-50% of baseline in both groups with no difference between groups. Gut oxygen (O2) delivery decreased during CPB in both groups, but O2 consumption remained unchanged. Gastric, ileal, and rectal mucosal pH decreased progressively, and portal venous blood pH also decreased in both groups, but there was no significant difference between groups.(ABSTRACT TRUNCATED AT 250 WORDS)


Asunto(s)
Agua Corporal , Puente Cardiopulmonar/efectos adversos , Dextranos/uso terapéutico , Sistema Digestivo/irrigación sanguínea , Sistema Digestivo/química , Mucosa Intestinal/fisiopatología , Isquemia/tratamiento farmacológico , Cloruro de Sodio/uso terapéutico , Animales , Sistema Digestivo/fisiopatología , Duodeno/irrigación sanguínea , Duodeno/química , Duodeno/fisiopatología , Femenino , Concentración de Iones de Hidrógeno , Soluciones Hipertónicas , Íleon/irrigación sanguínea , Íleon/química , Íleon/fisiopatología , Mucosa Intestinal/irrigación sanguínea , Mucosa Intestinal/química , Isquemia/metabolismo , Isquemia/fisiopatología , Yeyuno/irrigación sanguínea , Yeyuno/química , Yeyuno/fisiopatología , Consumo de Oxígeno/fisiología , Recto/irrigación sanguínea , Recto/química , Recto/fisiopatología , Flujo Sanguíneo Regional , Estómago/irrigación sanguínea , Estómago/química , Estómago/fisiopatología , Porcinos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA